Owner only: item control page
Antibody therapies and their challenges in the treatment of age-related macular degeneration
Volz, Cornelia and Pauly, Diana (2015) Antibody therapies and their challenges in the treatment of age-related macular degeneration. European Journal of Pharmaceutics and Biopharmaceutics 95, pp. 158-172.Date of publication of this fulltext: 19 Dec 2024 07:23
Article
Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | European Journal of Pharmaceutics and Biopharmaceutics | ||||
| Publisher: | ELSEVIER SCIENCE BV | ||||
|---|---|---|---|---|---|
| Place of Publication: | AMSTERDAM | ||||
| Volume: | 95 | ||||
| Page Range: | pp. 158-172 | ||||
| Date | 2015 | ||||
| Institutions | Medicine > Lehrstuhl für Augenheilkunde | ||||
| Identification Number |
| ||||
| Keywords | ENDOTHELIAL GROWTH-FACTOR; ALTERNATIVE COMPLEMENT PATHWAY; ANTI-ALPHA-5-BETA-1 INTEGRIN ANTIBODY; BEVACIZUMAB AVASTIN THERAPY; D MONOCLONAL-ANTIBODY; CHOROIDAL NEOVASCULARIZATION; INTRAVITREAL INFLIXIMAB; AMYLOID-BETA; AUTOIMMUNE-DISEASES; RETINAL DISEASES; Age-related macular degeneration; Therapeutic antibody; Intravitreal; Anti-angiogenic; Anti-complement system; Anti-inflammatory; Anti-amyloid beta; Clinical studies | ||||
| Dewey Decimal Classification | 600 Technology > 610 Medical sciences Medicine | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Yes | ||||
| Item ID | 60126 |
Export bibliographical data
Owner only: item control page
Altmetric
Altmetric